TBIO.OTC.PinkTelesis Bio INC

Form 4: Telesis Bio Inc. Director Frank Witney Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


Director Frank Witney reports acquisition and disposal of Telesis Bio Inc. stock and stock options.

Summary

  • On July 6, 2023, Frank Witney, a director of Telesis Bio Inc., was granted 46,752 restricted stock units (RSUs) and acquired 70,129 stock options with an exercise price of $1.54.
  • On May 1, 2024, Witney was granted an additional 48,354 RSUs and acquired 30,362 stock options with an exercise price of $0.3557.
  • The RSUs represent a contingent right to receive one share of Telesis Bio Inc.'s common stock for each RSU, vesting based on continued service.
  • The stock options also vest based on continued service, typically on the earlier of the one-year anniversary of the grant date or the date of the annual meeting of the Issuer's stockholders following the date of grant.
  • Following these transactions, Witney beneficially owns 115,736 shares of common stock and 30,362 stock options.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment, but the granting of equity could be seen as a positive sign of alignment between management and shareholders.

Positives

  • The granting of RSUs and stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.

Future Outlook

The vesting of RSUs and stock options is contingent upon the Reporting Person's continued service with the company.

Industry Context

Form 4 filings are a standard part of regulatory compliance for corporate insiders, providing transparency into their transactions in the company's securities.

Stakeholder Impact

  • Shareholders may view the granting of RSUs and stock options to a director as a positive sign, aligning their interests with management.

Key Dates

DateDescription
07/06/2023Reporting Person was granted restricted stock units and stock options.
05/01/2024Reporting Person was granted restricted stock units and stock options.
05/03/2024Date of signature.
01/01/202528,113 of the RSUs shall vest on this date.

Keywords

Telesis Bio Inc., Frank Witney, Form 4, Beneficial Ownership, RSU, Stock Options, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.